# argenx vs Cencora: valuation, size and margins compared

URL: https://funkfolio.com/compare/argx-vs-cor

> argenx ($59.6B, P/E 32.8) and Cencora ($66.9B, P/E 19.5) compared: size, valuation, margins, debt, cash and price change.

---

## argenx vs Cencora

argenx (ARGX), health care, and Cencora (COR), health care, side by side on market value, valuation, margins, balance sheet and price change. Higher and lower are marked; neither is called better.

Cencora is worth $66.9B on the stock market and argenx $59.6B: Cencora is valued at 12% more. argenx trades at 32.8 times earnings and Cencora at 19.5; operating margins in their latest fiscal years were 25.4% and 0.82%. Over the past year argenx's share price has moved +3.53% and Cencora's -1.30%.

### Key facts

- **argenx market value:** $59.6B
- **Cencora market value:** $66.9B
- **argenx P/E:** 32.8
- **Cencora P/E:** 19.5
- **argenx revenue:** $4.2B FY to 2025-12-31
- **Cencora revenue:** $321.3B FY to 2025-09-30
- **Superinvestors holding both:** 0

Market values as of 18 Nov 2026, 00:20 UTC.

argenx vs Cencora: every measure side by side

| Measure | argenx | Cencora |
| --- | --- | --- |
| Sector | Health Care | Health Care |
| Country | Belgium | United States |
| Fiscal year ends | 2025-12-31 | 2025-09-30 |
| Size |  |  |
| Market cap | $59.6B lower | $66.9B higher |
| Revenue | $4.2B lower | $321.3B higher |
| Earnings | $1.3B lower | $1.6B higher |
| Employees | 1,863 | — |
| Total assets | $8.7B lower | $76.6B higher |
| Valuation |  |  |
| P/E | 32.8 higher | 19.5 lower |
| P/S | 14.4 higher | 0.2 lower |
| P/B | — | 18.2 |
| Dividend yield | — | 0.67% |
| Profitability |  |  |
| Operating margin | 25.4% higher | 0.82% lower |
| Balance sheet |  |  |
| Net assets | $7.3B higher | $1.5B lower |
| Total liabilities | $1.4B lower | $74.8B higher |
| Total debt | — | $7.7B |
| Cash on hand | $3.5B lower | $4.4B higher |
| Price change |  |  |
| Today | -0.36% higher | -1.79% lower |
| 1 year | +3.53% higher | -1.30% lower |

Market value, P/E, P/B, dividend yield and price changes are from live quotes (Yahoo Finance; prices may be delayed 15 minutes or more). Revenue, earnings, operating margin and the balance-sheet figures are from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day. P/S sets today's market value against the latest fiscal year's revenue. “Higher” and “lower” compare the two numbers only; a higher P/E or more debt is not better. Dividend yield and P/B are shown only for companies based in the US. A dash means no figure is on file.

### Share price over one year

Each company's share price rebased to 100 on Nov 17, 2025, so the two lines start together. Price only: dividends are not included. Last: argenx 101.9, Cencora 96.0.

- argenx (ARGX)
- Cencora (COR)

argenx and Cencora share prices over one year, rebased to 100: argenx ends at 101.9, Cencora at 96.0.

**The chart as a table**

Month-end share prices rebased to 100

| Month end | ARGX | COR |
| --- | --- | --- |
| Nov 28, 2025 | 98.1 | 101.1 |
| Dec 31, 2025 | 90.5 | 92.5 |
| Jan 30, 2026 | 90.4 | 98.4 |
| Feb 27, 2026 | 82.5 | 102.0 |
| Mar 31, 2026 | 78.6 | 86.1 |
| Apr 30, 2026 | 84.1 | 84.4 |
| May 29, 2026 | 89.9 | 73.8 |
| Jun 30, 2026 | 99.8 | 77.5 |
| Jul 31, 2026 | 91.8 | 85.3 |
| Aug 31, 2026 | 111.0 | 88.7 |
| Sep 30, 2026 | 103.2 | 82.3 |
| Oct 30, 2026 | 96.0 | 90.6 |
| Nov 17, 2026 | 101.9 | 96.0 |

### Which superinvestors hold them

From each tracked investor's latest 13F filing. A 13F lists long positions in US-listed shares at a quarter end, filed up to 45 days later.

#### Both (0)

None of the tracked investors.

#### argenx only (2)

- [Frank Sands](https://funkfolio.com/gurus/frank-sands) 1.0%
- [Ron Baron](https://funkfolio.com/gurus/ron-baron) 0.2%

#### Cencora only (3)

- [Steve Cohen](https://funkfolio.com/gurus/steve-cohen) 0.3%
- [Ken Griffin](https://funkfolio.com/gurus/ken-griffin) 0.2%
- [Israel Englander](https://funkfolio.com/gurus/israel-englander) 0.2%

Percentages are each holding's share of that investor's reported portfolio. [Who owns ARGX](https://funkfolio.com/stock/ARGX/superinvestors) · [Who owns COR](https://funkfolio.com/stock/COR/superinvestors)

### More on argenx

- [argenx (ARGX) stock page](https://funkfolio.com/stock/ARGX)
- [argenx market cap](https://funkfolio.com/stock/ARGX/market-cap)
- [argenx revenue](https://funkfolio.com/stock/ARGX/revenue)
- [argenx P/E ratio](https://funkfolio.com/stock/ARGX/pe-ratio)
- [argenx operating margin](https://funkfolio.com/stock/ARGX/operating-margin)
- [argenx total debt](https://funkfolio.com/stock/ARGX/total-debt)
- [Largest health care companies](https://funkfolio.com/companies/sector/health-care)

### More on Cencora

- [Cencora (COR) stock page](https://funkfolio.com/stock/COR)
- [Cencora market cap](https://funkfolio.com/stock/COR/market-cap)
- [Cencora revenue](https://funkfolio.com/stock/COR/revenue)
- [Cencora P/E ratio](https://funkfolio.com/stock/COR/pe-ratio)
- [Cencora operating margin](https://funkfolio.com/stock/COR/operating-margin)
- [Cencora total debt](https://funkfolio.com/stock/COR/total-debt)
- [Largest health care companies](https://funkfolio.com/companies/sector/health-care)

### Further comparisons

#### argenx against its closest peers

- [argenx vs Edwards Lifesciences](https://funkfolio.com/compare/argx-vs-ew)
- [argenx vs Becton, Dickinson](https://funkfolio.com/compare/argx-vs-bdx)
- [argenx vs Cardinal Health](https://funkfolio.com/compare/argx-vs-cah)
- [argenx vs Boston Scientific](https://funkfolio.com/compare/argx-vs-bsx)

#### Cencora against its closest peers

- [Cencora vs Takeda Pharmaceutical](https://funkfolio.com/compare/cor-vs-tak)
- [Cencora vs Boston Scientific](https://funkfolio.com/compare/bsx-vs-cor)
- [Cencora vs Cardinal Health](https://funkfolio.com/compare/cah-vs-cor)

### Learn

- [What market capitalization is and is not](https://funkfolio.com/learn/markets/market-capitalization)
- [P/E ratio explained](https://funkfolio.com/learn/stocks/pe-ratio)
- [Market cap vs enterprise value](https://funkfolio.com/learn/markets/market-cap-vs-enterprise-value)

### Questions and answers

**Which is bigger, argenx or Cencora?**

By market value, Cencora is the larger: $66.9B against $59.6B for argenx. By revenue in its latest fiscal year, Cencora is the larger: $321.3B against $4.2B for argenx.

**Which has the higher P/E ratio?**

argenx: 32.8, against 19.5 for Cencora. A higher P/E means the market pays more for each dollar of the last twelve months' earnings; on its own it does not say which is the better value.

**Which has the higher operating margin?**

argenx: 25.4%, against 0.82% for Cencora. Operating margin is operating income as a share of revenue in the latest fiscal year.

**Which superinvestors own both argenx and Cencora?**

None of the tracked superinvestors holds both in their latest 13F filing. 2 hold argenx and 3 hold Cencora.

### Cite this page

Funkfolio, “argenx vs Cencora”, data as of 18 November 2026. https://funkfolio.com/compare/argx-vs-cor

Underlying data: Yahoo Finance quotes; SEC annual reports collected 2026-11-12; 13F filings.
